These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20459421)

  • 21. Haemodynamic and metabolic agents in the treatment of stable angina: publication review.
    Jackson G
    Coron Artery Dis; 2001 Feb; 12 Suppl 1():S22-4. PubMed ID: 11286303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Anti-ischemic efficacy of combination of trimetazidine with enalapril in patients with stable effort angina and metabolic syndrome].
    Petelina TI; Gapon LI; Bakhmatova IuA; Zhevagina IA; Kalinina VA; Todosiĭchuk VV; Kuznetsov VA
    Kardiologiia; 2005; 45(8):17-22. PubMed ID: 16091635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antiischemic efficacy of trimetazidine in patients with intermittent claudication and effort angina].
    Syrkin AL; Artiukhina EG; Kanorskiĭ SG; Chuntyzheva MM
    Kardiologiia; 2003; 43(7):49-52. PubMed ID: 12891299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of trimetazidine in the treatment of diabetic microangiopathy in ischaemic heart disease].
    Fi Z; Kovács G; Szentes V
    Orv Hetil; 2015 May; 156(19):765-8. PubMed ID: 26039915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Trimetazidine addition to antianginal therapy: effects on efficacy and quality of life in patients with stable angina treated outpatiently].
    Ter Arkh; 2012; 84(4):38-41. PubMed ID: 22774489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increase of adenosine plasma levels after oral trimetazidine: a pharmacological preconditioning?
    Blardi P; de Lalla A; Volpi L; Auteri A; Di Perri T
    Pharmacol Res; 2002 Jan; 45(1):69-72. PubMed ID: 11820865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficacy of ramipril, carvedilol, and trimetazidine MR in improvement of quality of life of patients after myocardial infarction].
    Gafurova RM; Abdullaev AA; Kadieva IA; Islamova UA; Mutalipov KhM
    Kardiologiia; 2010; 50(12):15-8. PubMed ID: 21591386
    [No Abstract]   [Full Text] [Related]  

  • 28. [Efficacy and tolerance of trimetazidine, a metabolic antianginal, in combination with a hemodynamic antianginal in stable exertion angina. TRIMPOL I, a multicenter study].
    Szwed H; Pachocki R; Domzal-Bochenska M; Szymczak K; Szydlowski Z; Paradowski A; Gajos G; Kaluza G; Kulon I; Wator-Brzezińska A; Elikowski W; Kuźniak M
    Presse Med; 2000 Mar; 29(10):533-8. PubMed ID: 10761517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-ischaemic efficacy and tolerability of trimetazidine administered to patients with angina pectoris: results of three studies.
    Szwed H; Hradec J; Préda I
    Coron Artery Dis; 2001 Feb; 12 Suppl 1():S25-8. PubMed ID: 11286304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of trimetazidine in the combined therapy of myocardial infarction with left ventricular dysfunction].
    Tereshchenko SN; Aleksandriia LG; Moiseev VS
    Kardiologiia; 2002; 42(10):19-21. PubMed ID: 12494051
    [No Abstract]   [Full Text] [Related]  

  • 31. The metabolic treatment of patients with coronary artery disease: effects on quality of life and effort angina.
    César LA; Gowdak LH; Mansur AP
    Curr Pharm Des; 2009; 15(8):841-9. PubMed ID: 19275648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-Anginal Effectiveness and Tolerability of Trimetazidine Modified Release 80 Mg Once Daily in Stable Angina Patients in Real-World Practice.
    Glezer MG; Vygodin VA;
    Adv Ther; 2018 Sep; 35(9):1368-1377. PubMed ID: 30105656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of trimetazidine in patients with recurrent angina: a subgroup analysis of the TRIMPOL II study.
    Ruzyllo W; Szwed H; Sadowski Z; Elikowski W; Grzelak-Szafranska H; Orszulak W; Szymczak K; Winter M
    Curr Med Res Opin; 2004 Sep; 20(9):1447-54. PubMed ID: 15383193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy comparison of trimetazidine with therapeutic alternatives in stable angina pectoris: a network meta-analysis.
    Danchin N; Marzilli M; Parkhomenko A; Ribeiro JP
    Cardiology; 2011; 120(2):59-72. PubMed ID: 22122948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concomitant Use of Ranolazine and Trimetazidine in Patients with Refractory Angina: An Initial Experience.
    Dourado LOC; Moreno CPD; Grobe SF; Gowdak LHW; Cesar LAM
    Arq Bras Cardiol; 2022 Oct; 119(4):619-621. PubMed ID: 35946755
    [No Abstract]   [Full Text] [Related]  

  • 36. The role of trimetazidine after acute myocardial infarction.
    Banach M; Rysz J; Goch A; Mikhailidis DP; Rosano GM
    Curr Vasc Pharmacol; 2008 Oct; 6(4):282-91. PubMed ID: 18855716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic stable angina pectoris.
    Jawad E; Arora R
    Dis Mon; 2008 Sep; 54(9):671-89. PubMed ID: 18725007
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical benefits of trimetazidine in patients with recurrent angina.
    Szwed H
    Coron Artery Dis; 2004 May; 15 Suppl 1():S17-21. PubMed ID: 15179124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Contribution of vastarel 20 mg (trimetazidine) in the treatment of vertigo: synopsis of clinical trials].
    Bouccara D
    Ann Otolaryngol Chir Cervicofac; 1999 Apr; 116(1):43-6. PubMed ID: 10367069
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of trimetazidine added to maximal anti-ischemic therapy in patients with advanced coronary artery disease.
    Grabczewska Z; Białoszyński T; Szymański P; Sukiennik A; Swiatkiewicz I; Koziński M; Kochman W; Grześk G; Kubica J
    Cardiol J; 2008; 15(4):344-50. PubMed ID: 18698543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.